Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Inovio Pharmaceuticals Inc. (INO)

21.45   1.72 (8.72%) 07-02 16:00
Open: 19.91 Pre. Close: 19.73
High: 22.4599 Low: 19.9
Volume: 52,201,682 Market Cap: 3,391M
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat, cure, and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance of cancerous cells and facilitate cross-strain protection against unmatched and matched pathogens. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 22.492 - 22.618 22.618 - 22.733
Low: 19.597 - 19.747 19.747 - 19.885
Close: 21.219 - 21.45 21.45 - 21.662

Technical analysis

as of: 2020-07-02 4:31:26 PM
Overall:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 29.36     One year: 39.47
Support: Support1: 11.13    Support2: 9.26
Resistance: Resistance1: 25.13    Resistance2: 33.79
Pivot: 20.35
Moving Average: MA(5): 25.96     MA(20): 18.38
MA(100): 11.05     MA(250): 6.04
MACD: MACD(12,26): 3.28     Signal(9): 2.87
Stochastic oscillator: %K(14,3): 48.63     %D(3): 64.72
RSI: RSI(14): 54.73
52-week: High: 33.79  Low: 1.92  Change(%): 619.8
Average Vol(K): 3-Month: 4176667  10-Days: 9316908

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
INO has closed below upper band by 45.9%. Bollinger Bands are 299% wider than normal. The large width of the bands suggest high volatility as compared to INO's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Sat, 04 Jul 2020
Inovio Stock: Buy, Sell, or Hold? - Motley Fool

Fri, 03 Jul 2020
Inovio Pharmaceuticals Inc. (INO) Shares have surged over 11.07 as It Announces Positive Interim Phase 1 Data of Potential Vaccine for COVID-19 - Frisco Herald

Thu, 02 Jul 2020
The Rejuvenation of Inovio Pharmaceuticals Inc. (NASDAQ:INO) - The Oracle Dispatch

Thu, 02 Jul 2020
$18.35 – $24.27: is It Good Range to Buy Inovio Pharmaceuticals, Inc. (INO)? - The News Heater

Wed, 01 Jul 2020
How Does Inovio Pharmaceuticals Inc (INO) Stock Rank in the Healthcare Sector? - InvestorsObserver

Tue, 30 Jun 2020
Why Inovio Pharmaceuticals Plunged 20% Today - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 158
Shares Float (M) 155
% Held by Insiders 2.69
% Held by Institutions 29.41
Shares Short (K) 25,780
Shares Short P. Month (K) 22,920

Stock Financials

EPS -1.160
EPS Est This Year -0.950
EPS Est Next Year -1.200
Book Value (p.s.) 1.260
Profit Margin
Operating Margin -4058.78
Return on Assets (ttm) -25.0
Return on Equity (ttm) -92.6
Qtrly Rev. Growth -53.1
Gross Profit (p.s.) -0.519
Sales Per Share 0.017
EBITDA (p.s.) -0.642
Qtrly Earnings Growth
Operating Cash Flow (M) -91
Levered Free Cash Flow (M) -50

Stock Valuations

PE Ratio -18.49
PEG Ratio
Price to Book value 17.02
Price to Sales 1299.33
Price to Cash Flow -37.33

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.